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The goal of this study was to determine the distribution of left ventricular 
(LV) systolic and diastolic dysfunctions and their prognostic value in canine par-
vovirus-infected dogs suffering from severe sepsis and septic shock (SS/SS). 
Twenty dogs with SS/SS (experimental group) and 18 healthy dogs (control 
group) were used in the study. Systolic and diastolic dysfunction was present in 
three (15%) and 14 (70%) diseased dogs, respectively, with both types of dys-
function present in two (10%) of the patients. These dogs were split into two 
groups: survivors (Sv, n = 14) and non-survivors (non-Sv, n = 6). The pulsed 
wave tissue Doppler (PW-TDI) septal mitral annulus systolic velocity (LVS’), an 
index of systolic dysfunction, had a high sensitivity and specificity to differentiate 
Sv and non-Sv animals, with values of 83.3% (95% CI: 41.6–98.4) and 83.3% 
(95% CI: 59.8–94.8), respectively, at an optimum cut-off point of ≥ 9.90. The 
PW-TDI septal early mitral annulus early-diastolic peak velocity (E’), an index of 
diastolic dysfunction, had the best sensitivity and specificity to differentiate Sv 
and non-Sv dogs, with values of 100% (95% CI: 55.2–100) and 100% (95% CI: 
78.9–100), respectively, at an optimum cut-off point of ≤ 6.50. Therefore, diastol-
ic dysfunction determined by E’ is a good independent outcome predictor.  
Key words: Sepsis, septic shock, dogs, parvovirus, myocardial dysfunction, 
echocardiography 
Canine parvovirus infection (CPVI) is a disease characterised by severe 
enteritis, profuse diarrhoea, and myocarditis due to not only canine parvovirus 
(CPV) but also to sepsis-induced myocardial depression (SiMD) in dogs (Otto, 
2007). 
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Transthoracic echocardiography (TTE) is a technique for guiding haemo-
dynamic management of cardiac function in human patients in the intensive care 
unit (ICU) (Rolando et al., 2015; Naseri et al., 2019). Tissue Doppler Imaging 
(TDI) provides a quantitative assessment of myocardial motion for the evaluation 
of systolic and diastolic function. TDI is less load dependent than conventional 
echocardiography techniques, and provides an assessment of global systolic and 
diastolic left ventricular (LV) function (Abdel-Hady et al., 2012; Souza Dantas 
and Costa, 2015). 
SiMD is a reversible dysfunction causing both systolic and diastolic dys-
function (Antonucci et al., 2014). Its incidence changes from 20 to 60% in the 
first three days after the onset of septic shock and generally returns to normal 
within 7–10 days (Vieillard-Baron et al., 2008; Vieillard-Baron, 2011). Mortality 
rate in patients with SiMD (70%) has been found to be significantly higher than 
in septic patients without SiMD (20%) (Parrillo et al., 1990; Bulmer, 2011). In 
humans, most studies have been performed on LV systolic dysfunction in sepsis 
(Krishnagopalan et al., 2002; Vieillard-Baron et al., 2008; Souza Dantas and Costa, 
2015); however, other forms of SiMD such as LV diastolic dysfunction and right 
ventricular dysfunction have been poorly evaluated (Bouhemad et al., 2008; 
Sturgess et al., 2010; Mahjoub et al., 2012; De Geer et al., 2015). All types of 
SiMD which may be reversible with resolution of the critical illness can be pre-
sent in isolation or in combination (Bouhemad et al., 2008). The studies on 
SiMD show that diastolic dysfunction is associated with a higher mortality rate 
than systolic dysfunction (Landesberg et al., 2012; Rolando et al., 2015). 
Although canine models have been used to evaluate the pathogenesis of 
cardiovascular dysfunction in sepsis, studies on clinical cases concerning its preva-
lence and prognosis is limited (Bulmer, 2011). Nelson and Thompson (2006) re-
ported that 16 dogs with severe systemic illness had LV dysfunction, twelve of 
which died or were euthanised within 15 days of hospitalisation. The average 
survival time of these dogs was 3.6 days. Kocaturk et al. (2012) stated that 43 dogs 
with CPVI had an elevated myocardial performance index (Tei) and increased 
serum cardiac troponin-I (cTnI). They found that these two parameters were also 
associated with a poor prognosis. The parameters used for evaluating systolic 
and diastolic dysfunction are essential for the monitoring of dogs with sepsis. Pa-
rameters such as ejection fraction (EF), LVS’, E’, E/E’, end-diastolic volume in-
dex (EDVI) and end-systolic volume index (ESVI) are often used to monitor sep-
tic human patients because of their good prognostic value. However, the im-
portance of these parameters, their association to one another, prognostic cut-off 
values for the best differentiation between survivors (Sv) and non-survivors (non-
Sv) and their applicability are unknown in dogs with severe sepsis and septic shock 
(SS/SS). 
Thus, the first goal of this study was to determine the distribution of LV 
systolic and diastolic dysfunctions and their prognostic value in canine parvovi-
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rus-infected dogs with SS/SS at admission to the ICU. The second goal was to 
determine prognostic cut-off values of the systolic and diastolic indices for the 
best differentiation between Sv and non-Sv animals. 
 
 
Materials and methods 
This study received ethics committee approval from the Faculty of Veteri-
nary Medicine, University of Selcuk (permit number: 2012/053). Twenty dogs 
suffering from CPVI with SS/SS (experimental group) and 18 healthy dogs (con-
trol group), incorporating both sexes and different breed types, ≤ 6 months of 
age, were used during the years 2014–2017. 
The control dogs, which were brought to the clinic for vaccination, were 
deemed healthy according to the clinical and laboratory examinations and nega-
tive commercial SNAP CPV antigen test (IDEXX, SNAPshot Dx). The 3-min 
ECG recordings and echocardiography examination results of the control dogs 
were also normal. 
The experimental dogs had clinical signs (vomiting and/or bloody diar-
rhoea) and laboratory findings (granulocytopenia and/or lymphopenia) compati-
ble with CPVI. All of them had a positive result by the SNAP CPV antigen test 
(IDEXX, SNAPshot Dx), and none of them had been vaccinated with commer-
cial parvovirus vaccine. Inclusion criteria in the experimental group were the 
recognition of systemic inflammatory response syndrome and SS/SS. The dogs 
were excluded from the study if they had congenital heart diseases, crude echo-
cardiographic images and measurements, and had received any other therapy. 
The presence of systemic inflammatory response syndrome, SS/SS in the 
experimental group of dogs was determined according to Silverstein and Hoper 
(2015). Sepsis associated with organ dysfunction, hypoperfusion, or hypotension 
was defined as severe sepsis. When severe sepsis did not respond to one bolus of 
IV fluid administration, it was regarded as septic shock. Hypotension was 
defined as systolic blood pressure (SBP) < 90 mmHg and mean blood pressure 
(MBP) < 70 mm Hg. A lactate level higher than 2.2 mmol/L was considered in-
dicative of hypoperfusion. 
Dogs of the experimental group were monitored (SBP and MBP, ECG re-
cordings) in the ICU (Compact 7, Medical Econet, Germany), and treated as de-
scribed by McMichael (2014). In cases with diastolic dysfunction, a colloid solu-
tion (hydroxyethyl starch 6%, 10 ml/kg/h, IV) was given to prevent the develop-
ment positive fluid balance due to the use of large amounts of crystalloid solution. 
All the clinical, laboratory and cardiologic examinations of the experi-
mental group of dogs were performed within 3 h of admission and thereafter at 6 
and 24 h of the treatment and on the day of discharge. Blood samples were ob-
tained for measurements of the concentration of cardiac troponin I (cTnI) by 
commercial ELISA (Mybiosource, USA). 
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Echocardiographic evaluation and definitions of left ventricular systolic  
and diastolic dysfunction 
TTE was applied in the ICU with an echocardiograph (SUIU, CZXL-
43C). Comprehensive 2-dimensional, M-mode and Doppler echocardiographic 
examinations were performed on all experimental dogs from the right parasternal 
views (long- and short-axis) and apical views (4-chamber). 
Left ventricular end-diastolic volume (EDV), end-systolic volume (ESV) 
and ejection fraction (EF) were measured using the Teichholz method using the 
software program of the echocardiogram as recommended by Turgut (2017). All 
measurements were made from three cardiac cycles and the mean values calcu-
lated. LV systolic dysfunction was described as mild (EF, 41–50%) and moder-
ate (EF, 31–40%) (Turgut, 2017). The EDV, ESV and cardiac output values were 
indexed according to body surface area, to obtain the EDV index (EDVI), ESV 
index (ESVI) and the cardiac index (CI). Mitral inflow PW-Doppler measure-
ment of peak E and A waves, E/A ratio, and peak E deceleration time were de-
termined. PW-TDI septal mitral annulus systolic (LVS’) and early diastolic (E’) 
velocities were obtained. The E/E’ ratio was then calculated (Nagueh et al., 
2009). Diastolic function was described based on the 2009 guidelines of the 
American Society of Echocardiography (ASE) (Nagueh et al., 2009) and classi-
fied as follows: if E’ ≥ 8 cm/s: normal; if E’ < 8 cm/s and E/A < 0.8: impaired re-
laxation; if E’ < 8 cm/s, E/A 0.8–1.5 and E/E’ 9–12: pseudonormal; if E’ < 8 cm/s, 
E/A > 2, DT < 160 ms and E/E’ ≥ 13: restrictive. 
Patient follow-up 
The experimental group of dogs was followed for 28-day mortality. A to-
tal of 65 echocardiograms were performed and the dogs were split into two 
groups (Sv and non-Sv) according to their treatment response. 
Statistical analysis 
All data were normalised by logarithmic transformation before analysis. 
Parametric data are reported as mean ± SD. These data were compared using an 
unpaired t-test. Nonparametric data are reported as median and range. Multivari-
ate regression analysis of ICU mortality was made to determine independent 
predictors of mortality. The prognostic values of LVS’, E’, EF and E/A for 28-
day mortality were evaluated using receiver operating characteristic (ROC) curve 
analysis in order to determine the prognostic cut-off value for the best differenti-
ation between Sv and non-Sv (SPSS Inc). Values at the level P < 0.05 were con-
sidered as significant. 
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Results 
Age, body weight and sex differences between Sv and non-Sv groups were 
not significant. The clinical and laboratory results including cTnI also did not show 
any significant difference between the Sv and non-Sv groups (Tables 1 and 2). 
Hypotension (SBP < 90 mmHg and/or MBP < 65 mmHg) was evident in 8 of 20 
CPV-infected dogs with severe sepsis, two of which still had low BP at the 6th 
hour of treatment (septic shock). 
In the experimental group, 15 dogs (75%) had at least one type of myocar-
dial dysfunction. Systolic (EF ≤ 50%) and diastolic dysfunction (E’ < 8 cm/s) 
was present in three (15%) and 14 (70%) patients, respectively, and both types of 
dysfunction were present in two (10%) patients. One dog with severe sepsis had 
neither systolic nor diastolic dysfunction. Within the LV diastolic dysfunction 
group, 11 patients (55%) had impaired relaxation and three (15%) had pseu-
donormal dysfunction. Within the LV systolic dysfunction group, two patients 
(10%) had mild dysfunction and one (5%) had moderate dysfunction. 
Fourteen dogs recovered and were discharged from the ICU (Sv). Six pa-
tients died (four during the first 6 h and two between the 2nd and 4th day of the 
study), resulting in an overall mortality rate of 30% (non-Sv). The average length 
of survival was 1.3 ± 1.4 days for the non-Sv dogs (n = 6; 30%), but the rest of 
the dogs (n = 14; 70%) survived. None of the dogs with systolic dysfunction 
died, while six dogs with diastolic dysfunction did not survive. The patients with 
an E’ < 8 cm/s had the worse survival outcome. Patients with systolic dysfunc-
tion (three patients) and the survived patients with LV diastolic dysfunction 
(eight patients) and two dogs with both systolic and diastolic types dysfunction 
on the initial echocardiogram had normal systolic and diastolic function on their 
final echocardiogram. 
Multivariate regression analysis of ICU mortality showed that LVS’, E’, 
EF and E/A were independent predictors of mortality (Table 2). The cardiologi-
cal findings on admission for the Sv and non-Sv are shown in Table 2. The EF 
for non-Sv dogs (74 ± 10.48%) was significantly higher than that of Sv (62.22 ± 
13.16%; P < 0.05) (Table 2). Higher LVS’ was determined in non-Sv dogs, com-
pared to Sv (P < 0.05) and control dogs (P < 0.05). In non-Sv dogs, the average 
E/A ratio and E’ were significantly lower (P < 0.05) than those of the control and 
Sv dogs (Table 2). The LVS’, an index of systolic dysfunction, had high sensitiv-
ity and specificity to differentiate Sv and non-Sv, with values of 83.3% (95% CI: 
41.6–98.4) and 83.3% (95% CI: 59.8–94.8), respectively, at an optimum cut-off 
point of ≥ 9.90. The E’, an index of diastolic dysfunction, had the best sensitivity 
and specificity to differentiate Sv and non-Sv, with values of 100% (95% CI: 
55.2–100) and 100% (95% CI: 78.9–100), respectively, at an optimum cut-off 
point of ≤ 6.50 (Table 3). 
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The sensitivity and specificity of EF and E/A were not high enough to dif-
ferentiate Sv and non-Sv (Table 3). 
Table 1 
Clinical and laboratory parameters (mean ± standard deviation and mid) in control dogs (n = 18) 
and survivor (n = 16) and non-survivors (n = 6) dogs with parvoviral enteritis 
Parameters Control Survivor Non-survivor 
Body temperature (°C) 41.37 ± 11.62 38.9 ± 0.87 38.53 ± 1.4 
Respiration rate (bpm) 27.77 ± 3.05 47.92 ± 16.36a 41.16 ± 16.53 
Dehydration rate 1 2.07 ± 0.91a 2.± 0.63a 
Capillary refill time (sec) 1 2.57 ± 0.51a 2.5 ± 0.54a 
Mucous membranes  2 2.42 ± 0.85 1.83 ± 0.98a 
Femoral pulse 2 1.5 ± 0.51a 1.16 ± 0.40a 
Mental state 4 2.± 0.55a 2a 
Diarrhoea 1 2.85 ± 0.36a 3a 
WBC (109/L) 14.57 8.68 ± 7.73a 7.64 ± 8.13 
Lymphocytes (109/L) 3.84 5.17 ± 4.24 5.23 ± 4.9 
Monocytes (109/L) 0.8 0.55 ± 0.8 0.95 ± 2.12 
Granulocytes (109/L) 9.1 ± 5.57 2.99 ± 3.02a 1.45 ± 2.04a 
RBC (1012/L) 5.83 ± 1.02 7.65 ± 1.26a 7.13 ± 1.18 
MCV (fL) 57.43 ± 6.26 61.14 ± 3.75 61.25 ± 4.30 
Hct (%) 33.35 ± 7.91 46.74 ± 8.07a 43.56 ± 8.85a 
MCHC (g/dL) 35.70 ± 17.39 30.92 ± 2.61 28.06 ± 4.26 
Hb (g/dL) 11.67 ± 1.18 14.76 ± 2.51a 12.45 ± 3.85 
pH 7.37 ± 0.03 7.31 ± 0.1 7.36 ± 0.06 
pCO2 (mmHg) 36.82 ± 3.40 40.77 ± 8.34 42.13 ± 9.22 
pO2 (mmHg) 37.19 ±6.24 29.14 ± 7.65
a 29.83 ± 6.67 
Na (mmol/L) 146.72 ± 6.41 141.92 ± 4.32a 141.33 ± 1.36 
K (mmol/L) 3.65 ± 0.51 3.61 ± 0.37 3.4 ± 0.67 
Lactate (mmol/L) 1.3 3.19 ± 2.23a 1.91 ± 1.24 
HCO3 (mmol/L) 22.76 ± 2.13 20.7 ± 3.61 23.91 ±7.78 
BE (mmol/L) –1.19 ± 2.72 –5.46 ± 4.79a –1.23 ± 8.26 
SO2 (%) 87.33 ± 4.31 47.62 ± 19.88
a 51.38 ± 18.33a 
Glucose (mg/dL) 93.38 ± 12.94 92.42 ± 30.4 112.66 ± 33.64 
BUN (mg/dL) 11. 19.57 ± 15.57 14.83 ± 10.53 
Creatinine (mg/dL) 0.5 0.58 ± 0.74 0.8 ± 0.54 
ALT (U/L) 27. 39.21 ± 30.86 101.± 80.27a 
ALP (U/L) 249.97 ± 152.1 305.71 ± 142.83 284.± 83.84 
Albumin (g/dL) 2.6 ± 0.46 2.67 ± 0.34 2.30 ± 0.23 
Protein (g/dL) 5.69 ± 1.01 5.72 ± 0.73 5.05 ± 0.44 
aSignificantly (P < 0.05) different from the control group. Mental state: comatose (1), depressive 
(2), alert (3), active (4); Diarrhoea: none (1), watery diarrhoea (2), haemorrhagic diarrhoea (3); 
Femoral pulse: normokinetic (2), hypokinetic (1); Mucous membranes: hyperaemic (1), normal (2), 
slightly pale (3), pale (4); Dehydration rate: < 5% (1); 6–8% (2); 9–10% (3); > 10% (4); Capillary 
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Table 2 
Echocardiographic parameters (mean ± standard deviation) and cardiac troponin I (mid) in control 
dogs (n = 18) and survivor (n = 14) and non-survivors (n = 6) dogs with parvoviral enteritis 
Parameters Control Survivor Non-survivor 
HR (BPM) 122.66 ± 24.81 179.92 ± 33.08a 195.83 ± 36.1a 
SBP (mmHg) 126.05 ± 17.94 117.5 ± 27.68 89.16 ± 32.93a 
MAP (mmHg) 93.38 ± 17.46 82.64 ± 25.96 68.16 ± 21.09a 
EDVI (mL/m2) 64.49 ± 17.19 30.54 ± 9.19a 28.17 ± 14.41a 
ESVI (mL/m2) 21.71 ± 5.35 11.47 ± 6.73a 13.3 ± 10.06a 
EF % 63.49 ± 4.5 62.22 ± 13.16 74.± 10.48b 
CI (mL/min/m2) 5547.38 ± 1041.94 3094.08 ± 764.26a 2768.37 ± 1184.8a 
LVS’ (cm/sec) 8.49 ± 1.3 8.49 ± 2.06 11.75 ± 2.37ab 
EPSS (mm) 0.30 ± 0.08 0.23 ± 0.11 0.25 ± 0.11 
E (cm/sec) 77.76 ± 13.28 55.51 ± 16.01a 41.85 ± 5.66a 
A (cm/sec) 53.33 ± 8.76 55.80 ± 23.68 49.85 ± 15.72 
E/A ratio 1.46 ± 0.17 1.16 ± 0.44a 0.78 ± 0.15ab 
E deceleration time (sec) 0.04 ± 0.01 0.06 ± 0.02 0.05 ± 0.01 
E’ (cm/sec) 10.87 ± 1.41 7.14 ± 1.91a 5.55 ± 1.26ab 
E/E’ 7.34 ± 0.76 7.12 ± 2.33 7.01 ± 1.55 
cTnI (pg/mL) 5.6 21.03 ± 22.2 22.4 ± 16.23 
EF = Ejection fraction; E/A ratio = Mitral ratio of peak early (E) to late diastolic filling velocity 
(A); cTnI = Cardiac troponin I; aSignificantly (P < 0.05) different from the control group; bSignifi-
cantly (P < 0.05) different from the survivor group 
Table 3 
Optimum cut-off values of PW-TDI septal mitral annulus systolic (LVS’), early diastolic velocities 
(E’), EF and E/A, and respective sensitivity, specificity, area under the curve (AUC), standard  
deviation (SD), and likelihood ratio of mortality prediction in CPV-infected dogs 
Item Cut-off AUC SE 









≥ 9.90 0.880 0.061 0.760–0.999 
83.3  
(41.6–98.4)
(P < 0.05) 
83.3 
(59.8–94.8) 
(P < 0.05) 
62.5 93.8 83.3 
E’  
(cm/s) 
≤ 6.50 1.000 0.000 1.000–1.000 
100  
(55.2–100)
(P < 0.001) 
100 
(78.9–100) 
(P < 0.001) 
100 100 100 
EF  
(%) 





46.3 78.2 45.3 





42.1 79.3 47.5 
PPV: positive predictive value; NPV: negative predictive value 
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Discussion 
SiMD is a well-known complication of sepsis in people (Nelson and 
Thompson, 2006; Dickinson et al., 2007). Reversible SiMD has been recognised 
in 20 to 60% of humans with sepsis (Martin et al., 2005; Subla et al., 2005; 
Vieillard-Baron, 2011). However, studies concerning SiMD in dogs are limited 
and the effect of SiMD on the prognosis in dogs is currently unknown. 
There is a general consensus that EF is the most often used index for eval-
uating LV systolic function. However, its association with clinical outcome has 
given conflicting results, especially in patients with SS/SS (Ho and Solomon, 
2006; Abdel-Hady et al., 2012; Naseri et al., 2019). Nelson and Thompson 
(2006) reported that 75% of dogs with an EF of less than 46% died or were eu-
thanised within 15 days of hospital admission. However, in humans, it was found 
that reversible systolic dysfunction was associated with higher survival rates 
compared to those who did not survive (Jardin et al., 1999; Vieillard-Baron et al., 
2008; Antonucci et al., 2014). In our study, three dogs with low EF (< 50%) sur-
vived. The difference in EF between Sv and non-Sv was significant (P < 0.05; 
Table 2). Nevertheless, the EF, an index of systolic dysfunction, had low sensi-
tivity and specificity to differentiate Sv and non-Sv, with values of 46% (95% 
CI: 52.4–81.3) and 49% (95% CI: 51.3–79.2), respectively, at an optimum cut-
off point of ≤ 50 (Table 3). Many hypotheses have been proposed to explain why 
survivors exhibited more marked myocardial depression (Hunter and Doddi, 
2010; Vieillard-Baron, 2011; Weng et al., 2012). However, the exact pathophys-
iology of myocardial dysfunction is unclear. Myocardial hibernation in sepsis 
has been determined (Levy et al., 2005). Myocardial hibernation is an adaptive 
response to preserve cardiac myocytes by downregulation of oxygen consump-
tion and energy requirements. Through this action, the activation of cell-death 
pathway may decrease and the future full recovery can start. The non-
significantly increased cTnI in our study can also explain that physical myocar-
dial injury is overlooked. Observed normal EF in most cases can be explained by 
persistent vasoplegia (decreased arterial tone). However, further serial studies are 
warranted to support this hypothesis.  
LVS’ is another parameter for LV systolic function. It has been proposed 
that LVS’ could be a better prognostic index than EF (Yu et al., 2007). Weng et 
al. (2012) found that non-Sv exhibited significantly higher LVS’ compared with 
Sv [11.0 cm/sec (9.1 to 12.5 cm/sec) versus 7.8 cm/sec (5.5 to 9.0 cm/sec)]. In 
our study, LVS’ also appeared to be a better prognostic index than EF. LVS’ 
provided high sensitivity and specificity to differentiate Sv and non-Sv, with val-
ues of 83.3% (95% CI: 41.6–98.4) and 83.3% (95% CI: 59.8–94.8), respectively, 
at an optimum cut-off point of ≥ 9.90 (Table 3). Although the LVS’ has ad-
vantages over EF, it is load dependent (Nguyen et al., 2007; Uemura et al., 
2011). It has been reported that EF may correspond to different levels of intrinsic 
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LV contractility. For instance, an EF of 55% may correspond to impressed in-
trinsic LV contractility in the presence of vasoplegia (Robotham et al., 1991). So, 
the finding of supernormal LVS’ in non-Sv in this study is not surprising (Table 2). 
Supernormal LVS’ may reflect a hyperkinetic state associated with persistent and 
profound vasoplegia. Thus, high LVS’ associated with persistent vasoplegia 
might be the cause of high mortality in dogs with SS/SS. However, further ex-
tensive studies need to be carried out in order to confirm our findings. 
Studies in humans have shown that both systolic and diastolic dysfunction 
developed in patients with SS/SS (Poelaert et al., 1997; Munt et al., 1998; Bou-
hemad et al., 2008). Landesberg et al. (2012) reported that 9.1% of patients with 
SS/SS had isolated systolic dysfunction and 14.1% had combined systolic and 
diastolic dysfunction. However, isolated diastolic dysfunction was more common 
(38%). In other studies, alarmingly high prevalence rates (60–84%) of left ven-
tricular diastolic dysfunction with increased mortality have also been found in 
septic patients (Landesberg et al., 2012; Rolando et al., 2015; Souza Dantas and 
Costa, 2015). The prognostic importance of diastolic dysfunction in dogs with 
SS/SS has not been adequately investigated. In this study, systolic (EF ≤ 50%) 
and diastolic dysfunction (E’ < 8 cm/s) were present in three (15%) and 14 (70%) 
patients, respectively, and both types of dysfunctions were present in two (10%) 
patients. Six dogs with diastolic dysfunction died. These results show that dias-
tolic dysfunction in dogs with SS/SS is common (14 cases). 
In humans, many studies have shown that E’ is a load-independent meas-
ure of diastolic dysfunction (Landesberg et al., 2012) and has prognostic im-
portance in cardiac diseases (Ho and Solomon, 2006; Yu et al., 2007). Sturgess 
et al. (2010) suggested that diastolic dysfunction was an independent predictor of 
mortality, better than cardiac biomarkers. In our study, E’ was the best independ-
ent predictor of 28-day mortality in dogs with SS/SS (Table 2). E’, an index of 
diastolic dysfunction, had the best sensitivity and specificity to differentiate Sv 
and non-Sv, with values of 100% (95% CI: 55.2–100) and 100% (95% CI: 78.9–
100), respectively, at an optimum cut-off point of ≤ 6.50 (Table 3). This result 
showed that LV diastolic dysfunction often developed in dogs with SS/SS, and 
E’ was a good independent predictor of mortality. Diastolic dysfunction may im-
pair LV dilatation and prevent stroke volume augmentation in response to fluid 
load, and the non-compliant LV may aggravate lung congestion. The developing 
non-cardiogenic pulmonary oedema may lead to pulmonary hypertension and 
right ventricle dysfunction. 
A low mitral E/A ratio (< 1) may be an indicator of impaired ventricular 
relaxation and, consequently, diastolic dysfunction (Lavine, 2006). In this study, 
the mean E/A ratio was lower (P < 0.05) in non-Sv dogs than in control and Sv 
dogs (Table 2). However, the E/A had low sensitivity and specificity to differen-
tiate Sv and non-Sv, with values of 45.2% (95% CI: 53.3–81.2) and 44.3% (95% 
CI: 41.3–69.5), respectively, at an optimum cut-off point of ≤ 0.98 (Table 3). So, 
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we can state that E/A cannot be an important independent predictor of mortality 
in dogs with SS/SS. 
In conclusion, echocardiographic systolic dysfunction determined by LVS’ 
was associated with increased mortality in CPV-infected dogs with SS/SS. Dias-
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